X @The Wall Street Journal
Mergers and Acquisitions - Pfizer to acquire weight-loss drug developer Metsera for up to $73 billion [1] Market Focus - Pfizer re-enters the growing obesity drug market [1]
Mergers and Acquisitions - Pfizer to acquire weight-loss drug developer Metsera for up to $73 billion [1] Market Focus - Pfizer re-enters the growing obesity drug market [1]